Livercancer
Conditions
Interventions
single arm:TACE
Sponsors
Tianjin Medical University Cancer Institute and Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. age from 18 to 75 years, males or females; 2. diagnosed as liver cancer by criteria; 3. diagnose as arteriovenous shunting by DSA; 4. With a prospected life expectancy of more than three months; 5. ECOG score 0-1; 6. with proper function of main organs; 7. with a proper pregnancy precaution within three months.
Exclusion criteria
Exclusion criteria: 1. With a high risk of fatal blooding; 2. suffered with a surgery of open injury, or bleedings; 3. CTCAE grade more than 3;or with a unhealing wound abbesses or fracture; 4. pregnant or breast feeding women; 5. Child-Paugh grade C; 6. Tumor burden more than 70% of liver; 7. Portal carcinoma thrombosis is completely blocked; 8. Severe coagulation dysfunction; 9. Severe cardiopulmonary insufficiency; 10. Diffuse or widespread metastasis; 11. With a prospected life expectancy of less than three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The successful of first embolisation; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-8 weeks recirculation rate;Embolization treatment efficiency;Adverse Events (AE); Serious Adverse Events (SAE); | — |
Countries
China
Contacts
Public ContactZhi Guo
Tianjin Medical University Cancer Institute and Hospital
Outcome results
None listed